Investigating the impact of silver Sulfadiazine (SSD) and Ciprofloxacin on Biofilm-related Pseudomonas Aeruginosa Infection
Author(s): Mohd. Fareedullah and Dr. Anuj Kumar Sharma
Abstract: Biofilm formation by Pseudomonas aeruginosa poses a significant challenge in clinical settings due to its resistance to conventional antibiotics. This study investigates the impact of silver sulfadiazine (SSD) and ciprofloxacin on biofilm-related Pseudomonas aeruginosa infection. In vitro assays demonstrate that both SSD and ciprofloxacin exhibit substantial efficacy in inhibiting biofilm formation and eradicating pre-formed biofilms of Pseudomonas aeruginosa. Furthermore, combination therapy with SSD and ciprofloxacin displays synergistic effects, suggesting a potential strategy for enhancing antimicrobial activity against biofilm-associated infections. These findings underscore the therapeutic potential of SSD and ciprofloxacin in combating biofilm-related Pseudomonas aeruginosa infections and highlight the importance of exploring alternative treatment approaches in the fight against antimicrobial resistance.
Pages: 74-79 | Views: 20 | Downloads: 9Download Full Article: Click Here
How to cite this article:
Mohd. Fareedullah, Dr. Anuj Kumar Sharma. Investigating the impact of silver Sulfadiazine (SSD) and Ciprofloxacin on Biofilm-related Pseudomonas Aeruginosa Infection. Int J Multidiscip Trends 2023;5(5):74-79.
Research Journals